Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

p60src and p72 Syk Tyrosine Kinases Activate Both Lw and CD44 to Mediate Sickle Red Blood Cell Adhesion to Endothelium

Edward Chiou, Rahima Zennadi, PhD

Blood (2012) 120 (21): 3223.

https://doi.org/10.1182/blood.V120.21.3223.3223

Published: 2012

Journal Articles

Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34 + chronic myeloid leukemia progenitors, preserving normal stem cells

Giovanni Reddiconto, Claudia Toto, Ilaria Palamà, Simone De Leo, Emanuela de Luca, Serena De Matteis, Luciana Dini, Carlo Gambacorti Passerini, Nicola Di Renzo, Michele Maffia, Addolorata Maria Luce Coluccia

Blood (2012) 119 (10): 2335–2345.

https://doi.org/10.1182/blood-2011-06-361261

Published: 2012

Journal Articles

Bortezomib, Lenalidomide, and Dexamethasone (VRD) Consolidation and Lenalidomide Maintenance in Frontline Multiple Myeloma Patients: Updated Results of the IFM 2008 Phase II VRD Intensive Program

Murielle Roussel, Nelly Robillard, Philippe Moreau, MD, Lotfi Benboubker, MD, PhD, Cyrille Hulin, MD, Gerald Marit, MD, PhD, Xavier Leleu, MD, PhD, Brigitte Pegourie, MD, Christophe Fruchart, MD, Denis Caillot, MD, Anne-Marie Stoppa, MD, Thierry Facon, MD, Soraya Wuilleme, MD, PhD, Hervé Avet-Loiseau, MD, PhD, Michel Attal, MD

Blood (2011) 118 (21): 1872.

https://doi.org/10.1182/blood.V118.21.1872.1872

Published: 2011

Journal Articles

Frontline Therapy with Bortezomib, Lenalidomide, and Dexamethasone (VRD) Induction Followed by Autologous Stem Cell Transplantation, VRD Consolidation and Lenalidomide Maintenance In Newly Diagnosed Multiple Myeloma Patients: Primary Results of the IFM 2008 Phase II Study

Murielle Roussel, Hervé Avet-Loiseau, Philippe Moreau, Anne Huynh, Lotfi Benboubker, Cyrille Hulin, Gerald Marit, Xavier Leleu, Brigitte Pegourie, Christophe Fruchart, Denis Caillot, MD, Anne-Marie Stoppa, Thierry Facon, Jean-Luc Harousseau, Michel Attal

Blood (2010) 116 (21): 624.

https://doi.org/10.1182/blood.V116.21.624.624

Published: 2010

Journal Articles

Lenalidomide (CC-5013; Revlimid®) Promotes Erythropoiesis in Myelodysplastic Syndromes (MDS) by CD45 Protein Tyrosine Phosphatase (PTP) Inhibition.

Alan F. List, MD, Myka Estes, Ann Williams, Ph.D., Madhavi Sekharam, Ph.D., Ukiyasu Ozawa, Ph.D., Gui Gao, M.D., Ph.D., Jerry Wu, Ph.D., Gui Gao, M.D., Ph.D., Lubomir Sokol, M.D., Ph.D.

Blood (2006) 108 (11): 1360.

https://doi.org/10.1182/blood.V108.11.1360.1360

Published: 2006

Journal Articles

Lyn Kinase Is Constitutively Activated, Controls the mTOR/p70S6K/4E-BP1 Pathway and Regulates Cell Proliferation in Acute Myeloid Leukemia.

Christian Recher, MD, Cedric Dos Santos, MD, Cecile Demur, MD, Valerie Bardet, MD,PhD, Nais Prade-Houdellier, Guy Laurent, MD,PhD, Bernard Payrastre, PhD

Blood (2006) 108 (11): 1946.

https://doi.org/10.1182/blood.V108.11.1946.1946

Published: 2006

Journal Articles

Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn

Mark Löwenberg, Jurriaan Tuynman, Joyce Bilderbeek, Timo Gaber, Frank Buttgereit, Sander van Deventer, Maikel Peppelenbosch, Daniel Hommes

Blood (2005) 106 (5): 1703–1710.

https://doi.org/10.1182/blood-2004-12-4790

Published: 2005

Includes: Supplemental data

Journal Articles

Core Epo Receptor Signaling Circuits in Adult Bone Marrow-Derived Primary Pro-Erythroblasts.

Don M. Wojchowski, PhD, Madhu Menon, MD, Vinit Karur, MD, Bethany Vincent, BA

Blood (2004) 104 (11): 1621.

https://doi.org/10.1182/blood.V104.11.1621.1621

Published: 2004

Journal Articles

Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60 c-src to mediate its mitogenicity

Daniel Cussac, Catherine Greenland, Serge Roche, Ren-Yuan Bai, Justus Duyster, Stephan W. Morris, Georges Delsol, Michèle Allouche, Bernard Payrastre

Blood (2004) 103 (4): 1464–1471.

https://doi.org/10.1182/blood-2003-04-1038

Published: 2004

NARROW

p60src and p72 Syk Tyrosine Kinases Activate Both Lw and CD44 to Mediate Sickle Red Blood Cell Adhesion to Endothelium

Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34 + chronic myeloid leukemia progenitors, preserving normal stem cells

Bortezomib, Lenalidomide, and Dexamethasone (VRD) Consolidation and Lenalidomide Maintenance in Frontline Multiple Myeloma Patients: Updated Results of the IFM 2008 Phase II VRD Intensive Program

Frontline Therapy with Bortezomib, Lenalidomide, and Dexamethasone (VRD) Induction Followed by Autologous Stem Cell Transplantation, VRD Consolidation and Lenalidomide Maintenance In Newly Diagnosed Multiple Myeloma Patients: Primary Results of the IFM 2008 Phase II Study

Lenalidomide (CC-5013; Revlimid®) Promotes Erythropoiesis in Myelodysplastic Syndromes (MDS) by CD45 Protein Tyrosine Phosphatase (PTP) Inhibition.

Lyn Kinase Is Constitutively Activated, Controls the mTOR/p70S6K/4E-BP1 Pathway and Regulates Cell Proliferation in Acute Myeloid Leukemia.

Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn

Core Epo Receptor Signaling Circuits in Adult Bone Marrow-Derived Primary Pro-Erythroblasts.

Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60 c-src to mediate its mitogenicity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only